series-c-plus
Stage
1
Investors
About
Medipost is a South Korean biotechnology company specializing in stem cell therapeutics, including stem cell banking and the development of advanced stem cell-based treatments for conditions such as osteoarthritis, bronchopulmonary dysplasia, and other diseases.
Explore Medipost's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.